Ligand profile
CHEMBL1181766
Bioactivity hit from ChEMBL on a similar protein.
Bound to: KP13_04428 — Adenosine deaminase
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1181766- UniProt (similar protein)
P56658- pchembl
- 9.000 (~1.0 nM)
- Target protein
- KP13_04428
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 89.8
- −1 ≤ LogP ≤ 5 1.74
- MW ≤ 500 Da 263.3
- LogP ≤ 5 1.74
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 7
- TPSA ≤ 140 Ų 89.8
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCCCCC(O)Cn1cc2c(N)ncnc2n1CCCCCCC(O)Cn1cc2c(N)ncnc2n1
InChI=1S/C13H21N5O/c1-2-3-4-5-6-10(19)7-18-8-11-12(14)15-9-16-13(11)17-18/h8-10,19H,2-7H2,1H3,(H2,14,15,16,17)InChI=1S/C13H21N5O/c1-2-3-4-5-6-10(19)7-18-8-11-12(14)15-9-16-13(11)17-18/h8-10,19H,2-7H2,1H3,(H2,14,15,16,17)
JZVBSOGGGSYFFD-UHFFFAOYSA-NJZVBSOGGGSYFFD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Binding sites
- PF00962
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1181766 →
- UniProt UniProt P56658 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1181766”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04428.
PDB 12
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).